Marinus Pharmaceuticals CEO to Participate in 6th Annual Evercore ISI HealthCONx Conference

Marinus Pharmaceuticals

RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has announced that its Chairman and Chief Executive Officer, Scott Braunstein, M.D., will be participating in a fireside chat at the prestigious 6th Annual Evercore ISI HealthCONx Conference.

The discussion is scheduled for Tuesday, November 28, starting at 12:55 p.m. Eastern Time. This participation marks an important opportunity for Marinus Pharmaceuticals to share insights about its pioneering work in seizure disorder therapeutics and its strategic direction going forward.

Evercore ISI HealthCONx Conference is a significant event in the healthcare sector, attracting thought leaders, industry experts, and investors from around the globe. It provides a platform for companies like Marinus Pharmaceuticals to showcase their achievements, strategies, and future plans to a global audience.

This fireside chat will offer an in-depth look into the company’s operations, providing investors with valuable insights into its innovative therapeutic developments and strategic objectives.

Investors and interested parties can access the event via a link on the Investors and Media page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. For those unable to attend the live webcast, a replay will be available approximately two hours after the event concludes and will remain accessible for up to 90 days.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Hear from Teleflex's CEO at the 36th Annual Piper Sandler Healthcare Conference!